Zuckerman A J, Zuckerman J N
WHO Collaborating Centre for Reference and Research on Viral Diseases, Royal Free Hospital and School of Medicine, London, U.K.
J Hepatol. 1995;22(1 Suppl):97-100.
The genetic and serological heterogeneity of hepatitis C virus and reinfections will make the development of a broad spectrum effective hepatitis C vaccine difficult. Important steps are identification of neutralising antibodies; reproducible techniques for tissue culture of HCV; the application of methods used for the development of vaccines against flaviviruses and pestiviruses, and the application of gene transfer techniques.
